Symbol: |
CRKL
|
Description: |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like [Source:HGNC Symbol;Acc:2363]
|
Location: |
Chr22:21271714-21308037[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:108
Gene |
Compound |
Gen_sig |
Exp_pattern |
CRKL |
AI 3-63984 |
0.025 |
Down |
CRKL |
AZETIDINE CARBOTHIOIC ACID, [1-(2-PYRIDINYL)ETHYLIDENE]HYDRAZIDE |
0.047 |
Down |
CRKL |
Tesimide |
0.039 |
Down |
CRKL |
NSC 373814 |
0.028 |
Down |
CRKL |
Neocuproin |
0.046 |
Down |
CRKL |
NSC 606398 |
0.029 |
Down |
CRKL |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.031 |
Up |
CRKL |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.003 |
Up |
CRKL |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.042 |
Down |
CRKL |
ANTINEOPLASTIC-625543 |
0.022 |
Down |
CRKL |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.035 |
Up |
CRKL |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.023 |
Down |
CRKL |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.02 |
Up |
CRKL |
ANTINEOPLASTIC-654379 |
0.025 |
Down |
CRKL |
NSC 65683 |
0.037 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:90
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:63
Total:5 Current:1
[First] [Prev]  Next Last 
|